Verified by AISci
Public source attached
Source status for this paper in the current AISci reviewed snapshot.
- Primary source
- CFI-FCI
- Correction status
- none
- Evidence coverage
- 1 sources / 1 publishers
- Last metadata check
- Jul 19, 2026
paperBiotech
Toronto Western “Investigational New Drug" Design & Discovery Lab (WIN-D3): an innovative centre of drug design and discovery for protein misfolding disorders, stroke, retinopathy and epilepsy.
Toronto Western “Investigational New Drug" Design & Discovery Lab (WIN-D3): an innovative centre of drug design and discovery for protein misfolding disorders, stroke, retinopathy and epilepsy.
Source-permitted summary
Toronto Western “Investigational New Drug" Design & Discovery Lab (WIN-D3): an innovative centre of drug design and discovery for protein misfolding disorders, stroke, retinopathy and epilepsy.
SourceCFI-FCIAI Reading Notes
Core signal
Structured notes generated from source-linked AISci metadata. Treat them as a reading aid, not a substitute for the paper.
- Core signal
- Toronto Western “Investigational New Drug" Design & Discovery Lab (WIN-D3): an innovative centre of drug design and discovery for protein misfolding disorders, stroke, retinopathy and epilepsy.
- Field context
- Protein and Drug Design
- People and labs
- Not stated in the reviewed source.
- Why it matters
- Recent source-backed research output for AISci Stage A browsing.
- Limits to check
- AISci rank score does not assess scientific quality or citation impact.
Research Workflow
Research Workflow
Recommended next steps for turning this signal into research action.
- Read original source
- Check DOI/OpenAlex
- Open relationship graph
- Review people and labs: Not stated in the reviewed source.
- Open linked event for AISci context
- Prepare journal-club PPT: AISci action coming next
- Plan replication checks: AISci action coming next
Publication facts
- Type
- paperSourceCFI-FCI
- Date
- Jun 26, 2026SourceCFI-FCI
- Venue
- CFI-FCISourceCFI-FCI
- Open access
- openSourceCFI-FCI
External IDs
Author order
No reviewed author edge is attached to this output.
Organizations
No source-confirmed author affiliation is attached.
Related events
Topics
Relationship evidence
Protein and Drug Design
Controlled AISci Stage A topic for Protein and Drug Design.
Toronto Western “Investigational New Drug" Design & Discovery Lab (WIN-D3): an innovative centre of drug design and discovery for protein misfolding disorders, stroke, retinopathy and epilepsy.
Publication signal: Toronto Western “Investigational New Drug" Design & Discovery Lab (WIN-D3): an innovative centre of drug design and discovery for protein misfolding disorders, stroke, retinopathy and epilepsy.
Timeline
- paperToronto Western “Investigational New Drug" Design & Discovery Lab (WIN-D3): an innovative centre of drug design and discovery for protein misfolding disorders, stroke, retinopathy and epilepsy.